| EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent | 2017/04/01 | English | 2,131 |
| PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2 | 2016/01/01 | English | 2,008 |
| Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials | 2006/03/01 | English | 1,979 |
| Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study | 2006/12/01 | English | 1,822 |
| The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours | 2016/07/01 | English | 1,785 |
| EAU Guidelines on Renal Cell Carcinoma: 2014 Update | 2015/05/01 | English | 1,671 |
| Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends | 2017/01/01 | English | 1,558 |
| Prevalence of Kidney Stones in the United States | 2012/07/01 | English | 1,531 |
| EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent | 2021/02/01 | English | 1,476 |
| EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013 | 2014/01/01 | English | 1,329 |
| Epidemiology and Risk Factors of Urothelial Bladder Cancer | 2013/02/01 | English | 1,306 |
| EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 | 2017/03/01 | English | 1,251 |
| Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2 | 2019/09/01 | English | 1,147 |
| EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease | 2011/01/01 | English | 1,062 |
| EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer | 2017/04/01 | English | 1,047 |
| International Variation in Prostate Cancer Incidence and Mortality Rates | 2012/06/01 | English | 1,043 |
| European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines | 2021/01/01 | English | 1,039 |
| EAU Guidelines on Renal Cell Carcinoma: The 2010 Update | 2010/09/01 | English | 1,023 |
| The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours | 2016/07/01 | English | 1,023 |
| Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer | 2017/03/01 | English | 1,000 |
| EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer | 2014/02/01 | English | 998 |
| EAU Guidelines on Interventional Treatment for Urolithiasis | 2016/03/01 | English | 970 |
| Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology | 2009/01/01 | English | 952 |
| European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update | 2019/05/01 | English | 885 |
| Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data | 2005/08/01 | English | 885 |
| EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 | 2013/10/01 | English | 879 |
| A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score | 2016/03/01 | English | 850 |
| EAU Guidelines on Prostate Cancer | 2008/01/01 | English | 849 |
| European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update | 2019/11/01 | English | 845 |
| Lower Urinary Tract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7) | 2003/12/01 | English | 810 |